Cantabria Labs, as a pharmaceutical company, invests a high percentage (12%) of its turnover in research to ensure maximum scientific efficacy and rigour.
HELIOCARE efficacy has been scientifically proven in over 50 studies published in leading international medical journals. Evidence demonstrates that it is not only effective in photoprotection, but also for the prevention of skin aging, actinic damage, sun allergies and dark spots.
With innovative products and an enterprising spirit, Cantabria Labs is today a point of reference for dermatological prescription in Europe (leader in Spain, Italy and Portugal) dedicated to improving the health and quality of life of people. With a presence in over 80 countries and subsidiaries in Italy, Portugal, Mexico, Morocco and China, Cantabria Labs has become a company of international renown.